Skip to main content
. 2018 Sep 13;67(12):2507–2517. doi: 10.2337/db18-0439

Table 1.

Baseline patient characteristics

FH FH+ Control
Number 10 10 5
Age (years) 45 ± 4 43 ± 5 49 ± 4
Sex (male/female) 7/3 6/4 2/3
Ethnicity (Mexican American/Caucasian/African American) 3/4/3 6/3/1 1/4
BMI (kg/m2) 24.3 ± 1.1 26.1 ± 1.2 24.5 ± 1.3
Body weight (kg) 75.6 ± 16.3 73.7 ± 10.9 72.6 ± 11.5
Fat-free mass (kg) 57.4 ± 12.8 51.5 ± 9.6 52.0 ± 11.2
HbA1c (%) 5.4 ± 0.1 5.4 ± 0.1 5.4 ± 0.1
FPG (mg/dL) 96.2 ± 2.6 100.7 ± 2.0 94.1 ± 5.2
2-h plasma glucose (mg/dL) OGTT 95 ± 5 109 ± 6 111 ± 5

Data are mean ± SD or n. There were no significant differences between the FH, FH+, and control groups.